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Malnutrition in patients treated for 
oral or oropharyngeal cancer - prevalence 














This study aimed to assess prevalence of malnutrition after treatment for oral/oropharyngeal cancer and to 
explore how oral symptoms relate to malnutrition after treatment. 
Methods
In this cross-sectional study, malnutrition (weight loss ≥10% in 6 months or ≥5% in 1 month), oral symptoms 
(EORTC QLQ-H&N35 questionnaire and additional questions to assess chewing problems), dental status, trismus 
and dietary intake were assessed in 116 adult patients treated for oral/oropharyngeal cancer. 
Results
Prevalence of malnutrition was 16% (95%CI: 10% to 23%). Prevalence of malnutrition in the period 0-3 months 
after treatment was signifi cantly higher (25%) than in the periods >3-12 months (13%) and >12-36 months 
after treatment (3%, p=0.008). Logistic multivariate regression analysis revealed that swallowing problems 
(p=0.021) and insuffi  cient protein intake were signifi cantly related to malnutrition (p=0.016). 
Conclusion
In conclusion, malnutrition is a considerable problem in patients treated for oral/oropharyngeal cancer, shortly 
after treatment. Of all oral symptoms, only swallowing problems were signifi cantly related to malnutrition in 
the period after treatment for oral/oropharyngeal cancer. 
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INTRODUCTION
Malnutrition has been defi ned as a subacute or chronic state of nutrition, in which a combination of 
undernutrition (insuffi  cient food intake) and infl ammation has led to a decrease in muscle mass, fat mass, and 
diminished function, i.e. immune function, cognitive function and muscle strength.1 In the period before head 
and neck cancer treatment, prevalence of severe weight loss, an indicator of malnutrition, varies from 19% to 
45%.2-5 
Malnutrition in head and neck cancer patients may have multiple causes. In the period before treatment, 
a major cause of malnutrition is insuffi  cient food intake, related to mechanical obstruction of food or pain 
caused by the tumor. In addition, infl ammatory activity induced by the tumor or cancer treatment, leading 
to catabolism of body cell mass may contribute to malnutrition.1 During and after treatment, malnutrition 
may develop or aggravate as a result of oral symptoms related to treatment, such as chewing and swallowing 
problems, pain, dry mouth, sticky saliva and taste disturbances.6
Although malnutrition or weight loss in the period before head and neck cancer treatment is often 
reported2,4,7, few data are available on prevalence of malnutrition after treatment for oral/oropharyngeal 
cancer. Previous studies in head and neck cancer patients treated with radiotherapy reported that prevalence 
of malnutrition is highest during radiotherapy and declines during the fi rst 3 months after radiotherapy.8,9 
These studies were heterogeneous regarding tumor localization and follow-up was limited to the fi rst 6 months 
after treatment. Consequently, prevalence of malnutrition in the long-term period after treatment for oral/
oropharyngeal cancer is unclear. 
It is well known that oral symptoms are risk factors for malnutrition.6 In the period before treatment, 
swallowing problems and pain in the mouth are identifi ed as main risk factors for malnutrition in head and 
neck cancer patients.2,10 Besides swallowing problems, patients treated for oral/oropharyngeal cancer may 
also suff er from chewing problems, due to either poor dental status or trismus. Edentulous patients often 
cannot wear their prosthesis for about 3 months after surgery and not uncommonly even up to 6 months after 
radiotherapy or chemoradiation, due to either radiation-induced mucositis, oral edema, tender oral mucosal 
surfaces, surgically induced changes in anatomy, or time needed to manufacture a new prosthesis. Additionally, 
trismus may result from scar tissue formation, as a result of surgery and from radiotherapy.11-13 The relationship 
between poor dental status and trismus and malnutrition in patients treated for oral/oropharyngeal cancer has 
not been studied before. Thus, it is unclear which oral symptom(s) are risk factors for malnutrition in the period 
after treatment for oral/oropharyngeal cancer.
The primary aim of this study was to test the hypothesis that prevalence of malnutrition in patients treated 
for oral/oropharyngeal cancer declines in the period after treatment. The secondary aim of the study was to test 
the hypothesis that swallowing problems, poor dental status and trismus are risk factors for malnutrition in the 




A convenience sample of 185 consecutive adult patients was asked to participate in this cross-sectional study 
between October 2004 and February 2006. These patients had been treated for oral or oropharyngeal cancer at 
the University Medical Center Groningen (UMCG), the Netherlands. Patients willing to participate underwent 
assessment after their visit to the physician. Diagnosis and treatment information were retrieved from medical 
records (Table 1). The study was approved by the Ethics Committee of the UMCG. Informed consent was 
obtained from all participants.
Inclusion criteria were: age ≥18 years and completed treatment for oral/oropharyngeal cancer ≤3 
years before study measurement. Treatment modalities were: surgery (local tumor excision and/or neck 
dissection); surgery and radiotherapy; radiotherapy (conventional or accelerated scheme); or radiotherapy 
with concomitant chemotherapy (carboplatin and 5-FU). Exclusion criteria were: a recurrent, residual or newly 
diagnosed tumor within 3 months after study measurement; edema due to liver, kidney or cardiac disease, 
to eliminate confounding by edema on body weight; uncontrolled diabetes mellitus to eliminate possible 
confounding in risk factors for weight loss.
Patients received dietary counseling from a dietitian working at the UMCG at time of diagnosis, during 
admission for surgery and weekly during radiotherapy. Duration of dietary counseling was generally limited to 
the fi rst half year after treatment. 
Assessment of malnutrition
Actual body weight (kilogram) was measured on a calibrated Seca 701 scale (Medical scales & Measuring 
Systems Seca Ltd., UK). Patients were measured in indoor clothing without shoes, after voiding the bladder. 
Weight for clothing (1.0-1.5 kg) was deducted from measured weight and this corrected weight was used 
for further analysis. Patients were asked for their body weight 1 and 6 months before study measurement. 
Pretreatment body weight was retrieved from medical records. Height was measured by a stadiometer (Seca 
222, Medical scales & Measuring Systems Seca ltd., UK). 
Percentage weight loss was calculated as: [(normal body weight - actual body weight) / normal body 
weight] x 100. Normal body weight was defi ned as body weight 1 month, or 6 months ago, or prior to 
treatment. Malnutrition was defi ned as weight loss ≥10% in 6 months or ≥5% in 1 month.4,14-18 BMI (kg/m2) 
was calculated as actual body weight / body height2.
Assessment of oral symptoms
The EORTC QLQ-H&N35 questionnaire was used to assess pain in mouth or throat, swallowing problems, senses 
problems, dry mouth and sticky saliva.19 Scale scores were calculated according to the manual and range from 
0 to 100.20 In addition, 3 questions regarding chewing problems were asked: 1) How much diffi  culty did you 
experience while eating solid food (like meat/solid bread)?; 2) How much diffi  culty did you experience while 
eating dry food (like cookies)?; 3) How much diffi  culty did you experience while eating soft food (like soft bread)? 
Possible answers to the additional questions were: 1) no diffi  culty; 2) little diffi  culty; 3) much diffi  culty; and 
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4) so much diffi  culty that eating was impossible. Answers 3) and 4) were dichotomized to ‘chewing problems’ 
and answers 1) and 2) to ‘no chewing problems’. Time frame for all questions was the week prior to assessment.
Dental status was assessed by number of natural teeth and/or presence or absence of a dental prosthesis. 
Dental status was considered poor if: edentate without prosthesis, edentate plus prosthesis in upper/lower 
jaw, or 1 edentulous jaw without prosthesis and 1-16 elements in the other jaw, otherwise dental status was 
considered acceptable.
Maximal mouth opening was measured 3 times using 2 calibrated callipers, 1 for edentates or partially 
dentate patients wearing their prosthesis and 1 for edentates not wearing their prosthesis. Trismus was defi ned 
as mean mouth opening ≤35 mm.21
Dietary intake and requirements
Dietary intake of the last week before measurement was assessed by means of dietary history, by a registered 
dietitian (HJ).22 Energy and protein intake were calculated using food calculation software (JOULE v.02r80 by 
iSOFT, The Netherlands). Nutritional requirements were estimated conform practical guidelines used in the 
UMCG: 30 or 35 kcal and 1.0 or 1.5 gram protein per kg actual body weight for well-nourished and malnourished 
patients respectively.23 For patients with a BMI>27, body weight equivalent to BMI=27 was calculated and 
used in the calculations, to correct for the relatively lower metabolic active muscle mass.24 Energy or protein 
intake <90% of requirements was considered insuffi  cient.
Patients were asked if they (partly) mashed or grinded their food. Patients not using oral food were able to 
answer with ‘not applicable’. 
Statistical analysis
Statistical analyses were performed using SPSS 16.0 for Windows software (SPPS Inc., Chicago, IL, USA). Interval 
after treatment (months) was categorized into 0-3 months after treatment, >3-12 months after treatment 
and >12-36 months after treatment. An independent samples Student’s t-test was used to test diff erences 
in continuous variables between 2 groups. A paired sample Student’s t-test was used to test diff erences in the 
mean of a continuous variable between 2 related groups. The Mann-Whitney U test was used to test diff erences 
in continuous variables between 2 groups if not distributed normally and in ordinal variables. The chi-square 
test was used to test diff erences between categorical variables. The Fisher’s exact test was used for categorical 
variables if ≥20% of the cells had an expected count less than 5, in 2 x 2 tables. 
The relationship between oral symptoms and malnutrition was analyzed in a multivariate logistic regression 
analysis. Malnutrition (yes/no) was entered as outcome variable. Age (years), gender (male versus female), 
tumor size (T1/T2 versus T3/T4), treatment with or without radiotherapy (surgery alone versus radiotherapy, 
surgery and radiotherapy or chemoradiation), single or combined treatment modality (surgery alone or 
radiotherapy alone versus surgery and radiotherapy or chemoradiation), interval after treatment (continuous 
variable (months)), dental status (poor versus acceptable), chewing problems (yes versus no), trismus (yes 
versus no), energy intake (suffi  cient versus insuffi  cient), protein intake (suffi  cient versus insuffi  cient), EORTC 
QLQ-H&N35 scale scores on swallowing problems, sticky saliva, senses problems, dry mouth, and pain in mouth 
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or throat were entered in the logistic regression analysis (method stepwise backward), entry criterion p≤0.05, 
removal criterion p>0.10.  
The relationship between percentual decline in pretreatment body weight and interval after treatment 
(categorical variable) was analyzed by one-way analysis of variance (ANOVA). 
In all analyses, statistical signifi cance was set at p<0.05.
RESULTS
Patients
Of the 185 eligible patients, 63 patients declined participation. Reasons to decline participation were: not 
interested in the study (33%, 23/63), fatigue (14%, 9/63), time investment too long (17%, 11/63) and unknown 
reasons (32%, 20/63). One-hundred and twenty-one patients were included in the study. Six patients had to be 
excluded because of either still being under treatment (n=1), tumor recurrence shortly after inclusion (n=1), 
or not being able to undergo nutritional assessment (n=4). Data of the remaining 116 patients (Table 1) were 
used in the various analyses on malnutrition, unless stated otherwise. Data on pretreatment body weight were 
complete in 112 patients. 
Nutritional assessment 
Overall prevalence of malnutrition was 16% (18/116, 95%CI: 10% to 23%). Prevalence of malnutrition in the 
period 0-3 months after treatment was signifi cantly higher (25%, 13/53) than in the periods >3-12 months 
after treatment (13%, 4/32) and >12-36 months after treatment (3%, 1/31) (p=0.008). Mean pretreatment 
body weight signifi cantly declined from 78.7±13.4 kg to 75.9±14.0 kg post-treatment (p<0.001) (mean 
decline 2.8±5.9 kg). Mean percentual decline in pretreatment body weight was 3.4±7.3% and no signifi cant 
diff erences in percentual decline in pretreatment body weight between the 3 intervals after treatment were 
found (p=0.220). Mean pretreatment BMI declined from 26.3±4.0 kg/m2 to 25.4±4.0 kg/m2 post-treatment 
(p<0.001) (mean decline 1.0±2.0 kg). Five percent (6/114) of all patients had a BMI<18.5 kg/m2.
Prevalence of malnutrition per treatment modality is presented in Table 2. Analyzed univariately, no 
diff erences in age (years), gender, tumor size (T1/T2 versus T3/T4), number of treated head and neck tumors 
and localization of last tumor (oral cavity versus oropharynx) were found between malnourished and well-
nourished patients. 
Oral symptoms
Analyzed univariately, malnourished patients scored worse on swallowing problems (p=0.005), dry mouth 
(p=0.032) and sticky saliva (p=0.011) compared to well-nourished patients (Table 3). 
Dietary intake  
Ninety-six percent of all patients (111/115) used an oral diet, either with (3%, 3/115) or without tube feeding 
(94%, 108/115) (Table 1). Of the patients using oral food (with or without tube feeding), 87% (97/111) used a 
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Table 1. Patient characteristics (n=116).
 










Squamous cell carcinoma 103 89
Salivary gland tumor 10 9
Other 3 3






Localization of last treated tumor
Oral cavity 82 71
Oropharynx 30 26
Otherb 4 3
Treatment of last tumor
Surgery 62 53




0 – 3 months 53 46
>3 – 12 months 32 28
>12 – 36 months 31 27
Type of dietc
Oral diet only 75 65
Oral diet with liquid dietary supplements   33 29
Oral diet and tube feeding 3 3
Tube feeding only 4 3
Interval between end of treatment and assessment (months), median (IQRd) 4.3 (1.4; 12.6)
a. Sum of percentages may be dissimilar to 100%, due to rounding.
b. Neck metastasis, maxillary sinus, unknown primary. 
c. N=115.
d. IQR: Interquartile range.
solid diet and 13% (14/111) a liquid/mashed diet. Patients using a liquid/mashed diet were signifi cantly more 
often malnourished (36%, 5/14) than patients using a solid diet (11%, 11/97, p=0.003). 
Mean actual intake was 2185±699 kcal and 83±24 gram protein. No signifi cant diff erences were found in 
intake between malnourished and well-nourished patients. Frequency of insuffi  cient protein intake, related to 
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Table 2. Prevalence of malnutrition related to last type of head and neck cancer treatment.
   
Type of treatment (n) Malnutrition
n %a
Surgery (62) 5 8
Treatment including radiotherapy (54) 13 24b
Radiotherapy (12) 3 25
Surgery and radiotherapy (before or after surgery) (35) 9 26
Chemoradiation (7) 1 14
a. Percentages are row percentages.
b. Prevalence of malnutrition in patients treated with radiotherapy, surgery and radiotherapy, or chemoradiation is signifi cantly 
higher than in patients treated with surgery alone (p=0.034), analyzed by chi-square test.
Table 3. Univariate analysis on malnutrition and oral symptoms.
Oral symptoms (n)a Malnutrition  No malnutrition p
n %b n %b
Chewing problems (31/116) 7 23 24 77 0.248c
Trismus (30/116) 7 23 23 77 0.239c
Poor dental status (37/116) 9 24 28 76 0.129d
median IQRe median IQR p
 Pain in mouth / throat (113) 25.0 14.6; 37.5 16.7 0.0; 25.0 0.092f
 Swallowing problems (113) 29.2 0.0; 52.1 0.0 0.0; 25.0 0.005f
 Senses problems (113) 16.7 0.0; 37.5 0.0 0.0; 16.7 0.211f
 Dry mouth (113) 66.7 33.3; 100.0 33.3 0.0; 66.7 0.032f
 Sticky saliva (113) 66.7 0.0; 100.0 0.0 0.0; 66.7 0.011f
a.  Number of valid observations (patients with this symptom/total number of patients).
b.  Percentages are row percentages.
c.  Analyzed by Fisher’s exact test.
d.  Analyzed by chi-square analysis, with continuity correction. 
e.  Interquartile range.
f.  Analyzed by Mann-Whitney U test.
requirements, was signifi cantly higher in malnourished patients (65%, 11/17) than in well-nourished patients 
(29%, 27/92 p=0.011). 
Multivariate logistic regression analysis
Swallowing problems and insuffi  cient protein intake were signifi cantly related to malnutrition in the logistic 
multivariate regression analysis (Table 4). 
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DISCUSSION 
The results of our study demonstrate that 1 out of 6 patients is malnourished after treatment for oral/
oropharyngeal cancer, with the highest prevalence of malnutrition shortly after treatment (1 out of 4 patients). 
The decline in prevalence of malnutrition within the fi rst year after treatment in our study is in accordance with 
results of other studies.8,9,25
Very limited data are available on prevalence of malnutrition after treatment for oral/oropharyngeal cancer. 
In a randomized clinical trial 48% of the patients was malnourished 3 months after start of radiotherapy. If 
patients received dietary counseling during and shortly after radiotherapy this percentage was 24%.8 In a 
study in head and neck cancer patients, in which malnourished patients received tube feeding during and 
after radiotherapy, prevalence of malnutrition was 27% and 6% in the third and sixth month after start of 
radiotherapy, respectively.25 Other studies on malnutrition in head and neck cancer patients focused on changes 
in nutritional status during and after treatment. In another randomized clinical controlled trial, performed in 
head and neck cancer patients treated with radiotherapy, nutritional status was deteriorated 3 months after 
treatment in all patients, but if patients received dietary counseling during radiotherapy this frequency was 
limited to 12%.9 In head and neck cancer patients not receiving dietary counseling during and after treatment, 
mean body weight signifi cantly declined with 2.3 ±4.0 kg during treatment and 2.2±5.5 kg in the period after 
treatment.5 In all of these studies prevalence of malnutrition declined in the fi rst 6 months after treatment in 
patients receiving dietary intervention.8,9,25
Of all oral symptoms, swallowing problems was the only one related to malnutrition in the logistic 
multivariate regression analysis. Although swallowing problems may be present in the long-term period after 
treatment for oral or oropharyngeal cancer26, swallowing problems are most severe during and shortly after 
treatment, due to radiation-induced mucositis and reduced mobility of the tongue due to surgery.6,27 Probably 
swallowing problems will cause malnutrition predominantly during treatment, and to a lesser extent in the 
period after treatment.
Poor dental status, trismus and chewing problems were no risk factors for malnutrition in the multivariate 
Table 4. Results of multivariate logistic regression analysis on malnutrition and oral symptoms. 
Variable ß SE ß OR 95% CI of OR p
Swallowing problems 0.03 0.01 1.03a 1.01 to 1.06 0.021
Insuffi  cient protein intakeb 1.60 0.66 4.93 1.35 to 18.06 0.016
Interval after treatment (months) -0.13 0.06 0.89 0.79 to 1.00 0.057
Constant -2.37 0.64 0.09 <0.001
ß = Regression Coeffi  cient; SE ß = Standard Error of ß; OR = Odds Ratio = eß; 95% CI of OR = 95% Confi dence Interval of Odds Ratio.
a.  A diff erence, for instance of 20 points in swallowing problems assessed by EORTC QLQ-H&N35, between 2 patients results in an OR for 
malnutrition of 1.82.
 (20 x ß = 20 x 0.03 = 0.06  e0.06 = 1.82).
b. 0 = absent; 1 = present.
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regression analysis. The multiple regression analysis corrected for confounders like change in diet and dietary 
treatment. Patients having chewing problems often change their diet into a soft, mashed or liquid diet. As 
nutritional density of a mashed or liquid diet is lower than that of a solid diet, these patients also are advised 
to use energy- and protein enriched liquid dietary supplements. Use of these supplements increases energy 
and protein intake and in turn decreases the risk for malnutrition. Only 1 other study assessed the relationship 
between dental status and malnutrition, but this study was performed in the period before treatment.10 In the 
latter study also no signifi cant relationship between these variables was found.10
No signifi cant relationship was found between percentual decline in body weight and interval after 
treatment. Mean decline in pretreatment body weight was limited to 3%. However, this 3% weight loss may 
be additional to weight loss that already may have developed before start of treatment. At time of diagnosis, 
34% of patients with oral/oropharyngeal cancer have already lost ≥10% of body weight in 6 months or ≥5% 
in 1 month.2 Additionally, in the current study diff erence between pretreatment and actual body weight ranged 
widely, indicating that a subgroup of patients fails to regain body weight to pre-illness or even pretreatment 
level. 
Although patients treated with radiotherapy were signifi cantly more frequently malnourished than 
patients treated with surgery alone in the univariate analysis, treatment with any type of radiotherapy was not 
signifi cantly related to malnutrition in the multivariate logistic regression analysis. In a prospective study on 
weight loss in head and neck cancer patients not receiving dietary counseling, patients treated with any type 
of radiotherapy lost signifi cantly more body weight than patients treated with surgery alone.5 In the current 
study, swallowing problems and insuffi  cient intake were more strongly related to malnutrition than type of 
treatment, in the period after treatment. 
Averagely, both malnourished and well-nourished patients seemed to have a rather adequate intake of 
energy and protein. However, insuffi  cient protein intake related to requirements was signifi cantly related to 
malnutrition. Energy and protein intake of our patients were similar to intake reported in other studies in head 
and neck cancer patients.5,8,9 On the other hand, mean body weight of our patients was higher than reported 
in 2 of these studies5,9, suggesting that dietary requirements of our patients were higher as well. As the 95% 
confi dence interval of the odds ratio of insuffi  cient protein intake was wide, the signifi cant relationship found 
between insuffi  cient protein intake and malnutrition should be interpreted with caution. This wide confi dence 
interval may be the result of insuffi  cient power due to the relatively low prevalence of malnutrition. On the 
other hand, the eff ect of protein intake on malnutrition may vary per patient. As malnutrition is the result of 
a combination of insuffi  cient intake and infl ammatory activity1, infl ammatory activity may have continued in 
the period after treatment.  
Unfortunately, currently a gold standard for the assessment of malnutrition does not exist.1 Weight loss is 
one of the criteria commonly used for assessment of malnutrition.18 Weight loss of ≥10% in 6 months/≥5% 
in 1 month is a generally accepted cutoff  for clinically relevant weight loss. Such a weight loss is associated 
with increased morbidity, such as impaired wound healing and reduced immune function.28,29 Besides that, 
weight loss of ≥10% in 6 months/≥5% in 1 month has shown to be of great prognostic value in the occurrence 
of major postoperative complications and has been associated with higher mortality and reduced quality of 
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life.4,14,16,17,28-31 The cutoff  point used in the current study was adopted by ASPEN to defi ne ‘nutritionally at risk 
adults’.32
Whereas weight loss refl ects acute malnutrition, underweight refl ects chronic malnutrition.33,34 Cutoff  
values for BMI varying from 18.5 to 20.0 kg/m2 have been used as an indicator of chronic malnutrition.18,35 
If a BMI<18.5 kg/m2 was added to our criteria for malnutrition, total prevalence of malnutrition would have 
risen to 19% (22/116). Prevalence of malnutrition in the period 0-3 months after treatment (28%, 15/53) also 
would have been signifi cantly higher than in the periods >3-12 months and >12-36 months after treatment 
(16%, 5/32 and 7%, 2/31, p=0.012). If this cutoff  for BMI is increased to BMI<20 kg/m2, total prevalence of 
malnutrition would have increased further to 22% (25/116). Prevalence of malnutrition per interval after 
treatment would have been 32% (17/53), 16% (5/32) and 10% (3/32) respectively (p=0.012). These fi ndings 
indicate that the choice of the cutoff  values is of the utmost importance for assessment of malnutrition. 
Obviously, a gold standard for the assessment of malnutrition is required.
To test the hypothesis that prevalence of malnutrition declines after treatment, we classifi ed patients into 
3 groups: 0-3 months after treatment, >3-12 months after treatment and >12-36 months after treatment. We 
chose these cutoff  values, to distinguish between acute and late side eff ects of head and neck cancer treatment. 
Radiation induced acute side-eff ects, such as mucositis, will diminish in the fi rst 3 months after treatment.6,36 In 
the period between 3 months and 1 year after treatment, existing oral symptoms may recover or may become 
chronic, as oral symptoms present 1 year after treatment usually do not recover in the period after that.27,37 
Furthermore, in the short-term period after treatment, infl ammatory activity related to treatment may still 
be present.38-40 One year after treatment, it is expected that patients reach a ‘steady state’ with regard to their 
nutritional problems.
A limitation of this study is the modest participation rate of 66%. In 14% of the patients not willing to 
participate fatigue has played a major role in the decision to refuse participation in the study. As it cannot 
be excluded that fatigue was the result of malnutrition, the modest participation rate may have resulted in 
underestimation of malnutrition.
Another limitation of the study is the use of prediction equations to estimate nutritional requirements.41-43 
Indirect calorimetry is the gold standard to assess energy requirements.44 However, for practical reasons it was 
not possible to perform indirect calorimetry in the current study. Therefore, energy requirements had to be 
estimated. We have chosen to compare energy intake to energy recommendations conform clinical practice 
in the UMCG. Use of prediction equations to predict energy expenditure may lead to prediction errors.41-43 
Such prediction errors may vary from 235 to 425 kcal, which is about 15-30% of resting energy expenditure as 
measured by indirect calorimetry.43 Therefore, evaluation of dietary intake in relation to requirements requires 
further research.
In conclusion, malnutrition is a considerable problem in patients treated for oral/oropharyngeal cancer, 
shortly after treatment. Of all oral symptoms, only swallowing problems were signifi cantly related to 
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